Proteomics in Chronic Prostatitis: Biomarker Discovery, Molecular Pathways, and Emerging Targets for Precision Medicine
Archives of Men's Health,
Vol. 8 No. 1 (2024),
31 July 2024
,
Page e9
https://doi.org/10.22037/amh.v8i1.48817
Abstract
Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a common and disabling urological disorder that affects quality of life in men. Despite accounting for most prostatitis cases, its causes remain unclear, involving immune dysregulation, oxidative stress, microbial factors, and epithelial barrier dysfunction. This uncertainty complicates diagnosis and treatment.
Proteomics offers a high-throughput approach to identify proteins and pathways involved in CP/CPPS. Recent studies have profiled urine, seminal plasma, prostatic secretions, and serum to uncover biomarkers linked to inflammation, oxidative stress, and microbial virulence. These findings provide insights into molecular endotypes, guide new classifications, and point toward novel therapeutic targets such as cytokine signaling, pyroptosis pathways, and heat shock proteins. Although technical variability and small cohort sizes remain major challenges, integration of proteomics with multi-omics platforms and explainable AI may transform CP/CPPS management by enabling personalized diagnostics and targeted interventions.
- Proteomics
- Inflammatory Cytokines
- Biomarkers
- Epithelial Barrier Dysfunction
- cpps
- Chronic Pelvic Pain Syndrome
- Precision Medicine
How to Cite
References
He, H., et al., Preclinical models and evaluation criteria of prostatitis. Frontiers in Immunology, 2023. Volume 14 - 2023.
Han, C.-L., et al., Comparison of cytokine levels in prostatic secretion between the IIIa and IIIb subtypes of prostatitis. Asian Journal of Andrology, 2024. 26(1).
Maeda, K., K. Shigemura, and M. Fujisawa, A review of current treatments for chronic prostatitis/chronic pelvic pain syndrome under the UPOINTS system. International Journal of Urology, 2023. 30(5): p. 431-436.
McArdle, A.J. and S. Menikou, What is proteomics? Archives of disease in childhood - Education & practice edition, 2021. 106(3): p. 178.
Lawrance, I.C., B. Klopcic, and V.C. Wasinger, Proteomics: An Overview. Inflammatory Bowel Diseases, 2005. 11(10): p. 927-936.
Ankney, J.A., A. Muneer, and X. Chen, Relative and Absolute Quantitation in Mass Spectrometry-Based Proteomics. Annu Rev Anal Chem (Palo Alto Calif), 2018. 11(1): p. 49-77.
Magdeldin, S., et al., Basics and recent advances of two dimensional- polyacrylamide gel electrophoresis. Clinical Proteomics, 2014. 11(1): p. 16.
Karpievitch, Y.V., et al., Liquid Chromatography Mass Spectrometry-Based Proteomics: Biological and Technological Aspects. The annals of applied statistics, 2010. 4 4: p. 1797-1823.
LaBaer, J. and N. Ramachandran, Protein microarrays as tools for functional proteomics. Curr Opin Chem Biol, 2005. 9(1): p. 14-9.
Wei, P., et al., Urinary Metabolomic and Proteomic Analyses in a Mouse Model of Prostatic Inflammation. Urine (Amst), 2019. 1: p. 17-23.
Hao, L., et al., Quantitative proteomic analysis of a genetically induced prostate inflammation mouse model via custom 4-plex DiLeu isobaric labeling. Am J Physiol Renal Physiol, 2019. 316(6): p. F1236-f1243.
Principe, S., et al., Identification of prostate-enriched proteins by in-depth proteomic analyses of expressed prostatic secretions in urine. J Proteome Res, 2012. 11(4): p. 2386-96.
Zhang, Y.D., et al., [Differential proteins in the prostate fluid with abnormal lecithin bodies and immunologic mechanism of chronic prostatitis patients]. Zhonghua Nan Ke Xue, 2021. 27(7): p. 609-615.
Utleg, A.G., et al., Proteomic analysis of human prostasomes. Prostate, 2003. 56(2): p. 150-61.
Kagedan, D., et al., Characterization of the seminal plasma proteome in men with prostatitis by mass spectrometry. Clin Proteomics, 2012. 9(1): p. 2.
Sharma, R., et al., Proteomic analysis of seminal fluid from men exhibiting oxidative stress. Reprod Biol Endocrinol, 2013. 11: p. 85.
Pilch, B. and M. Mann, Large-scale and high-confidence proteomic analysis of human seminal plasma. Genome Biol, 2006. 7(5): p. R40.
Hamza, G.M., et al., Proteomics of prostate cancer serum and plasma using low and high throughput approaches. Clinical Proteomics, 2024. 21(1): p. 21.
Signore, M., et al., Diagnostic and prognostic potential of the proteomic profiling of serum-derived extracellular vesicles in prostate cancer. Cell Death & Disease, 2021. 12(7): p. 636.
Kagedan, D., et al., Characterization of the seminal plasma proteome in men with prostatitis by mass spectrometry. Clinical Proteomics, 2012. 9(1): p. 2.
Roumeguère, T., et al., Oxidative stress and prostatic diseases. Mol Clin Oncol, 2017. 7(5): p. 723-728.
Ihsan, A.U., et al., Role of oxidative stress in pathology of chronic prostatitis/chronic pelvic pain syndrome and male infertility and antioxidants function in ameliorating oxidative stress. Biomedicine & Pharmacotherapy, 2018. 106: p. 714-723.
Kaltsas, A., et al., Oxidative Stress in Benign Prostatic Hyperplasia: Mechanisms, Clinical Relevance and Therapeutic Perspectives. Diseases, 2025. 13(2): p. 53.
Meng, J., et al., Testosterone regulates tight junction proteins and influences prostatic autoimmune responses. Horm Cancer, 2011. 2(3): p. 145-56.
Bhat, A.A., et al., Tight Junction Proteins and Signaling Pathways in Cancer and Inflammation: A Functional Crosstalk. Frontiers in Physiology, 2019. Volume 9 - 2018.
Wang, K., et al., Tight junction protein claudin-1 is downregulated by TGF-β1 via MEK signaling in benign prostatic epithelial cells. The Prostate, 2020. 80(14): p. 1203-1215.
Shang, Y., D. Cui, and S. Yi, Opening tight junctions may be key to opening the blood-prostate barrier. Med Sci Monit, 2014. 20: p. 2504-7.
Drake, R.R., et al., Clinical collection and protein properties of expressed prostatic secretions as a source for biomarkers of prostatic disease. J Proteomics, 2009. 72(6): p. 907-17.
Deng, A.-Q., et al., The role of microbiota in the chronic prostatitis/chronic pelvis pain syndrome: a review. Frontiers in Microbiology, 2025. Volume 16 - 2025.
Lipsky, B.A., I. Byren, and C.T. Hoey, Treatment of Bacterial Prostatitis. Clinical Infectious Diseases, 2010. 50(12): p. 1641-1652.
Mitsumori, K., et al., Virulence characteristics of Escherichia coli in acute bacterial prostatitis. J Infect Dis, 1999. 180(4): p. 1378-81.
Rokka, A., et al., Mass spectrometric identification of diagnostic markers for chronic prostatitis in seminal plasma by analysis of seminal plasma protein clinical samples. Cellular and Molecular Biology, 2017. 63(7): p. 35-39.
Hao, L., et al., Quantitative proteomic analysis of a genetically induced prostate inflammation mouse model via custom 4-plex DiLeu isobaric labeling. American Journal of Physiology-Renal Physiology, 2019. 316(6): p. F1236-F1243.
Cao, Z., D.T. Sloper, and N. Nakamura, Identification of Altered Proteins in the Plasma of Rats With Chronic Prostatic Inflammation Induced by Estradiol Benzoate and Sex Hormones. ACS Omega, 2021. 6(22): p. 14361-14370.
Zhang, F.X., et al., Chronic prostatitis/chronic pelvic pain syndrome induces metabolomic changes in expressed prostatic secretions and plasma. Asian J Androl, 2025. 27(1): p. 101-112.
Principe, S., et al., Identification of Prostate-Enriched Proteins by In-depth Proteomic Analyses of Expressed Prostatic Secretions in Urine. Journal of Proteome Research, 2012. 11(4): p. 2386-2396.
Drabovich, A.P., et al., Multi-omics Biomarker Pipeline Reveals Elevated Levels of Protein-glutamine Gamma-glutamyltransferase 4 in Seminal Plasma of Prostate Cancer Patients. Mol Cell Proteomics, 2019. 18(9): p. 1807-1823.
Shoskes, D.A., et al., Neuroinflammatory gene expression in chronic prostatitis/chronic pelvic pain syndrome patients: insights into etiology and phenotype biology. Transl Androl Urol, 2021. 10(8): p. 3340-3347.
Al-Daffaie, F.M., et al. Metabolomics and Proteomics in Prostate Cancer Research: Overview, Analytical Techniques, Data Analysis, and Recent Clinical Applications. International Journal of Molecular Sciences, 2024. 25, DOI: 10.3390/ijms25105071.
Hachem, S., et al., Contemporary Update on Clinical and Experimental Prostate Cancer Biomarkers: A Multi-Omics-Focused Approach to Detection and Risk Stratification. Biology (Basel), 2024. 13(10).
Sadeesh, N., M. Scaravilli, and L. Latonen Proteomic Landscape of Prostate Cancer: The View Provided by Quantitative Proteomics, Integrative Analyses, and Protein Interactomes. Cancers, 2021. 13, DOI: 10.3390/cancers13194829.
Ho, D.-R., et al. Beneficial Effects of Inflammatory Cytokine-Targeting Aptamers in an Animal Model of Chronic Prostatitis. International Journal of Molecular Sciences, 2020. 21, DOI: 10.3390/ijms21113953.
Zhao, M., et al., Relationship between pyroptosis-mediated inflammation and the pathogenesis of prostate disease. Frontiers in Medicine, 2023. Volume 10 - 2023.
Ikwegbue, P.C., et al., Interplay between heat shock proteins, inflammation and cancer: a potential cancer therapeutic target. Am J Cancer Res, 2019. 9(2): p. 242-249.
Ikwegbue, P.C., et al. Roles of Heat Shock Proteins in Apoptosis, Oxidative Stress, Human Inflammatory Diseases, and Cancer. Pharmaceuticals, 2018. 11, DOI: 10.3390/ph11010002.
Vaezzadeh, A.R., et al., Proteomics and opportunities for clinical translation in urological disease. J Urol, 2009. 182(3): p. 835-43.
Tonry, C.L., et al. The Role of Proteomics in Biomarker Development for Improved Patient Diagnosis and Clinical Decision Making in Prostate Cancer. Diagnostics, 2016. 6, DOI: 10.3390/diagnostics6030027.
Lee, K.H., et al., Addressing statistical challenges in the analysis of proteomics data with extremely small sample size: a simulation study. BMC Genomics, 2024. 25(1): p. 1086.
Frantzi, M., A. Bhat, and A. Latosinska, Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development. Clinical and Translational Medicine, 2014. 3(1): p. e7.
Liu, J., et al., Multi-Omics Analysis Reveals Changes in the Intestinal Microbiome, Transcriptome, and Methylome in a Rat Model of Chronic Non-bacterial Prostatitis: Indications for the Existence of the Gut-Prostate Axis. Front Physiol, 2021. 12: p. 753034.
Resurreccion, E.P. and K.-w. Fong The Integration of Metabolomics with Other Omics: Insights into Understanding Prostate Cancer. Metabolites, 2022. 12, DOI: 10.3390/metabo12060488.
Gómez-Cebrián, N., et al., Metabolic Phenotyping in Prostate Cancer Using Multi-Omics Approaches. Cancers (Basel), 2022. 14(3).
Hussein, A., M. Prasad, and A. Braytee, Explainable AI Methods for Multi-Omics Analysis: A Survey. arXiv preprint arXiv:2410.11910, 2024.
Xin, L., et al., Artificial Intelligence for Central Dogma-Centric Multi-Omics: Challenges and Breakthroughs. arXiv preprint arXiv:2412.12668, 2024.
- Abstract Viewed: 210 times
- pdf Downloaded: 172 times